Share This
An agency in UK sought to relabeled all products of Glucosamine from medicinal to just supplemental, The UK's major food supplements trade association has collaborated with the local medicines regulator to fight against a huge pharma that has escalated a complaint to High Court legal action –seeking to ban glucosamine and unlabeled the product both as food and a medicine in the whole of UK and possibly other market in EUROPE. Glucosamine has become popular both as a medicinal and supplemental, it deals primarily on osteoarthritis (the most widespread type of arthritis). It is produce naturally in our body and one of the major components to maintain a healthy cartilage.
Studies have pointed out that glucosamine may trigger production of cartilage-building proteins. In one study -chondroitin may stop the production of cartilage-destroying enzymes and reduce inflammation in the process. There is no study so far that proves any serious side effects concerning glucosamine or chondroitin substances. The most common side effects are increased intestinal gas. One of the important role of glucosamine and chondroitin sulfate supplements is that they are fighting agents to slow or prevent the degeneration of joint cartilage, the basic cause of osteoarthritis (A type of arthritis). Glucosamine and chondroitin may also help reduce existing joint pain. For the same basis above, group of agencies are fighting together to overturn the decision of the court banning the product away from the market.
Joining forces
The move saw the MHRA and the UK’s Health Food Manufacturers’ Association (HFMA) – groups which are not always in agreement – joining forces to quash the challenge.
HFMA executive director Graham Keen said at the time that there would be “serious and far-reaching implications” if the challenge were successful and the HFMA filed a substantial submission to the Court in support of the MHRA’s position.
Keen further warned “Not only would the highly valuable food glucosamine market be lost to the health food trade, there would also immediately be implications for the future food supplement status of other substances, in particular those that have licensed equivalents – for example, cod liver oil, folic acid, and vitamins D and B12. A worrying precedent might also be established whereby the MHRA’s ability to review products on a case-by-case basis is seriously threatened.”
“This is a watershed moment for our industry. We can’t afford …
Today, Glucosamine and chondroitin product stays safely in many stores in UK this because of the appeal of some people who believed in its healing ability concerning knee pain. The product was reclassified and remained as medicinal and supplemental food.
You can read the rest of the article at Nyrnaturalnews.com
Leave a Reply